Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia
Acute myeloid leukemia is a clonal but heterogeneous disease differing in molecular
pathogenesis, clinical features and response to chemotherapy. This latter frequently consists of a …
pathogenesis, clinical features and response to chemotherapy. This latter frequently consists of a …
Human immunodeficiency virus‐associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy
BACKGROUND: Plasmablastic lymphoma (PBL) is a rare and aggressive B‐cell lymphoma
strongly associated with human immunodeficiency virus (HIV) infection. The authors …
strongly associated with human immunodeficiency virus (HIV) infection. The authors …
[HTML][HTML] Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
…, CE Escobar, J Ortiz-Martín, JL Diez-Martin… - Journal of hematology & …, 2020 - Springer
Background Patients with cancer have been shown to have a higher risk of clinical severity
and mortality compared to non-cancer patients with COVID-19. Patients with hematologic …
and mortality compared to non-cancer patients with COVID-19. Patients with hematologic …
COVID‐19 coagulopathy: an in‐depth analysis of the coagulation system
…, S Osorio‐Prendes, JL Díez‐Martín… - European Journal of …, 2020 - Wiley Online Library
… José Luis Díez-Martín … José Luis Díez-Martín … JL Díez-Martín coordinated the team.
All authors contributed to literature review on the topic and critically reviewed the manuscript. …
All authors contributed to literature review on the topic and critically reviewed the manuscript. …
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry
Objective: To analyse the durability of the responses after haematopoietic stem cell
transplantation (HSCT) for severe systemic sclerosis (SSc) and determine whether the high …
transplantation (HSCT) for severe systemic sclerosis (SSc) and determine whether the high …
Comparable survival between HIV+ and HIV− non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation
JL Díez-Martín, P Balsalobre, A Re… - Blood, The Journal …, 2009 - ashpublications.org
Autologous stem cell transplantation (ASCT) has been successfully used in HIV-related
lymphoma (HIV-Ly) patients on highly active antiretroviral therapy. We report the first …
lymphoma (HIV-Ly) patients on highly active antiretroviral therapy. We report the first …
[PDF][PDF] Autologous stem-cell transplantation in patients with HIV-related lymphoma
P Balsalobre, JL Díez-Martín, A Re, M Michieli… - J Clin …, 2009 - researchgate.net
Purpose Peripheral-blood autologous stem-cell transplantation (ASCT) in patients with HIV-related
lymphoma (HIV-Ly) has been reported as a safe and useful procedure. Herein we …
lymphoma (HIV-Ly) has been reported as a safe and useful procedure. Herein we …
[HTML][HTML] Donor cell–derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review
…, D Serrano, J Gayoso, JL Díez-Martín… - Biology of Blood and …, 2018 - Elsevier
Abstract Development of de novo hematologic malignancies in donor cells after allogeneic
stem cell transplantation (allo-SCT) provides a useful in vivo model to study the process of …
stem cell transplantation (allo-SCT) provides a useful in vivo model to study the process of …
[HTML][HTML] Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study
…, MJ Penalva, J García-Suárez, JL Díez-Martín… - …, 2021 - journals.lww.com
Patients with cancer are poorly represented in coronavirus disease 2019 (COVID-19) series,
and heterogeneous series concerning hematology patients have been published. This …
and heterogeneous series concerning hematology patients have been published. This …
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide
BACKGROUND Incidence of graft‐versus‐host disease (GVHD) in haploidentical bone
marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is low, whereas …
marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is low, whereas …